Feb 26, 2025 | Defective Drugs, Depo-Provera, Multidistrict Litigation, Product Liability
For decades, Depo-Provera has been a widely used injectable contraceptive. It often receives praise for its convenience and long-term effectiveness. However, recent lawsuits are emerging linking Depo-Provera to serious health risks, including the development of...
Nov 19, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, an injectable contraceptive containing the synthetic hormone medroxyprogesterone acetate (MPA), has been widely used for decades as an effective birth control method. While it is valued for its convenience and long-term efficacy, concerns have emerged...
Nov 5, 2024 | Defective Drugs, Defective Product, Depo-Provera, Personal Injury, Product Liability
Depo-Provera, a widely-used injectable contraceptive, has offered a convenient birth control option for millions of women worldwide. Yet, while the drug’s appeal has long rested on its effectiveness and quarterly dosing schedule, serious side effects and long-term...
Aug 6, 2024 | Defective Drugs, Defective Product, Medical News, Product Liability
Tepezza (teprotumumab) has emerged as a groundbreaking treatment for Thyroid Eye Disease (TED), a condition that can cause bulging eyes, double vision, and other serious issues. While Tepezza has offered hope to many patients, it has also raised concerns due to...
Jul 25, 2024 | Defective Drugs, Defective Product, Medical News, Personal Injury, Product Liability
In recent years, Tepezza, a groundbreaking treatment for Thyroid Eye Disease (TED), has offered hope to many patients suffering from this debilitating condition. However, as its usage has increased, so too have reports of severe side effects, particularly those...
